New Key Statistics Module, Z-Score and F-Score
SZSE:301130 Key Ratios
Market Cap ¥ M | 2,184.13 |
Enterprise Value ¥ M | 1,722.10 |
P/E(ttm) | 48.88 |
PE Ratio without NRI | 51.00 |
Forward PE Ratio | -- |
Price/Book | 2.44 |
Price/Sales | 9.10 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.49 |
Revenue (TTM) ¥ M | 240.00 |
EPS (TTM) ¥ | 0.55 |
Beneish M-Score | -2.23 |
10-y EBITDA Growth Rate % | 4.20 |
5-y EBITDA Growth Rate % | -6.90 |
y-y EBITDA Growth Rate % | 29.30 |
EV-to-EBIT | 29.28 |
EV-to-EBITDA | 29.28 |
PEG | -- |
Shares Outstanding M | 80.80 |
Net Margin (%) | 18.57 |
Operating Margin % | 15.11 |
Pre-tax Margin (%) | 21.17 |
Quick Ratio | 10.63 |
Current Ratio | 11.17 |
ROA % (ttm) | 4.39 |
ROE % (ttm) | 4.70 |
ROIC % (ttm) | 6.75 |
Dividend Yield % | 0.99 |
Altman Z-Score | 19.07 |
SZSE:301130 Number of Guru Trades
SZSE:301130 Volume of Guru Trades
Gurus Latest Trades with SZSE:301130
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301130 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co Ltd Insider Transactions
No Available Data